Jounce Therapeutics Inc.

NAS: JNCE

GO
/marketstate/country/us

After Hours

/zigman2/quotes/210277760/composite

$

2.20

Change

0.00 0.00%

Volume

Volume 3,431

Sep 29, 2022, 4:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/210277760/composite

Today's close

$ 2.30

$ 2.20

Change

-0.10 -4.35%

Day low

Day high

$2.12

$2.32

Open
Open: 2.28

52 week low

52 week high

$2.12

$9.81

Open

Market cap

$118.90M

Average volume

247,976

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.55

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/jnce

MarketWatch News on JNCE

  1. Jounce Therapeutics upgraded to strong buy from outperform at Raymond James

    7:48 a.m. May 6, 2022

    - Tomi Kilgore

  2. Jounce Therapeutics upgraded to outperform from market perform at Raymond James

    7:50 a.m. Sept. 14, 2021

    - Tomi Kilgore

  3. Jounce Therapeutics upgraded to strong buy from outperform at Raymond James

    8:54 a.m. March 25, 2020

    - Tomi Kilgore

  4. How to invest in biotech stocks like a Nobel Prize winner

    11:47 a.m. Oct. 24, 2019

    - Michael Brush

  5. Jounce Therapeutics downgraded to underweight from neutral at J.P. Morgan

    9:16 a.m. Nov. 14, 2018

    - Tomi Kilgore

  6. Jounce Therapeutics stock price target cut to $12 from $28 at J.P. Morgan

    7:58 a.m. June 4, 2018

    - Tomi Kilgore

  7. Jounce Therapeutics downgraded to neutral from overweight at J.P. Morgan

    7:58 a.m. June 4, 2018

    - Tomi Kilgore

  8. Selling Nvidia and Cavium, Buying Citrix Systems

    6:52 a.m. Jan. 11, 2018

    - Barron's Online

  9. Consumer Confidence Seen to Be Waning

    4:33 a.m. July 22, 2017

    - Barron's Online

  10. Celgene Shows Savvy as Gilead Keeps Backsliding

    7:08 a.m. March 16, 2017

    - Barron's Online

  11. Jounce Therapeutics started at overweight with $28 stock price target at J.P. Morgan

    9:27 a.m. Feb. 21, 2017

    - Tomi Kilgore

/news/nonmarketwatch/company/us/jnce

Other News on JNCE

  1. Jounce (JNCE) SELECT Study Fails to Meet Goal, Stock Down

    10:24 a.m. Aug. 31, 2022

    - Zacks.com

  2. 10-Q: JOUNCE THERAPEUTICS, INC.

    12:38 p.m. Aug. 4, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. Notable earnings before Thursday's open

    10:45 a.m. Aug. 3, 2022

    - Seeking Alpha

  4. Mass General Brigham, Inc Buys 2, Sells 3 in 2nd Quarter

    9:00 p.m. July 27, 2022

    - GuruFocus.com

  5. Jounce Therapeutics (JNCE) Investor Presentation - Slideshow

    3:04 p.m. May 24, 2022

    - Seeking Alpha

  6. 10-Q: JOUNCE THERAPEUTICS, INC.

    1:20 p.m. May 5, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  7. Jounce Therapeutics GAAP EPS of -$0.72 misses by $0.15

    7:20 a.m. May 5, 2022

    - Seeking Alpha

  8. Jounce Therapeutics Q1 2022 Earnings Preview

    12:32 p.m. May 4, 2022

    - Seeking Alpha

  9. Notable earnings before Thursday's open

    11:07 a.m. May 4, 2022

    - Seeking Alpha

  10. Jounce Therapeutics (JNCE) Investor Presentation - Slideshow

    3:14 p.m. March 7, 2022

    - Seeking Alpha

  11. 10-K: JOUNCE THERAPEUTICS, INC.

    4:21 p.m. March 2, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  12. Loading more headlines...
/news/pressrelease/company/us/jnce

Press Releases on JNCE

Rates »

Link to MarketWatch's Slice.